ArticleFrontiers in immunology2022

Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma.

Xiaomi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.